Oral Presentation ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Epigenetic profiling of human parathyroids: reduced activity of CaSR-specific enhancer in hyperparathyroidism** (#200)

Michael Mannstadt 1
  1. Massachusetts General Hospital and Havard Medical School, Boston, MA, United States

TBC**